Evidence map›Paper›PMID 35099392›Full record

ArticleJMIR cancer2022

Automated Clinical Practice Guideline Recommendations for Hereditary Cancer Risk Using Chatbots and Ontologies: System Description.

Jordon B Ritchie, Lewis J Frey, Jean-Baptiste Lamy, Cecelia Bellcross, Heath Morrison, Joshua D Schiffman, Brandon M Welch

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Chatbots for breast cancer education: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Jordon B Ritchie *Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID https://orcid.org/0000-0001-7503-6073
Lewis J Frey *Health Equity and Rural Outreach Innovation Center, Ralph H. Johnson Veterans Affairs Health Care System, Charleston, SC, United States.ORCID https://orcid.org/0000-0003-2816-4309
Jean-Baptiste Lamy *Université Sorbonne Paris Nord, LIMICS, Sorbonne Université, INSERM, F-93000, Bobigny, France.ORCID https://orcid.org/0000-0002-5477-180X
Cecelia Bellcross *Department of Human Genetics, Emory University, Atlanta, GA, United States.ORCID https://orcid.org/0000-0002-5974-0172
Heath Morrison *Doxy.me, Charleston, SC, United States.ORCID https://orcid.org/0000-0003-4380-7034
Joshua D Schiffman *Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0002-6968-7694
Brandon M Welch *Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID https://orcid.org/0000-0002-2214-9282
Medical University of South Carolina · USEmory University · USInserm · FRRalph H. Johnson VA Medical Center · USUniversity of Utah · US

Funding

Improving cancer family history collection through social networking and artificial intelligenceK07CA211786 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WELCH, BRANDON M · 2016 to 2020
$867k
Data-Driven Methods to Identify Social Determinants of HealthI01HX003379 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI Lewis James Frey, Mulugeta Gebreselassie Gebregziabher · 2021 to 2027
–
HSRD VA I01 HX003379NCI NIH HHS K07 CA211786
6 · The paper itself

Abstract

backgroundIdentifying patients at risk of hereditary cancer based on their family health history is a highly nuanced task. Frequently, patients at risk are not referred for genetic counseling as providers lack the time and training to collect and assess their family health history. Consequently, patients at risk do not receive genetic counseling and testing that they need to determine the preventive steps they should take to mitigate their risk.

objectiveThis study aims to automate clinical practice guideline recommendations for hereditary cancer risk based on patient family health history.

methodsWe combined chatbots, web application programming interfaces, clinical practice guidelines, and ontologies into a web service-oriented system that can automate family health history collection and assessment. We used Owlready2 and Protégé to develop a lightweight, patient-centric clinical practice guideline domain ontology using hereditary cancer criteria from the American College of Medical Genetics and Genomics and the National Cancer Comprehensive Network.

resultsThe domain ontology has 758 classes, 20 object properties, 23 datatype properties, and 42 individuals and encompasses 44 cancers, 144 genes, and 113 clinical practice guideline criteria. So far, it has been used to assess >5000 family health history cases. We created 192 test cases to ensure concordance with clinical practice guidelines. The average test case completes in 4.5 (SD 1.9) seconds, the longest in 19.6 seconds, and the shortest in 2.9 seconds.

conclusionsWeb service-enabled, chatbot-oriented family health history collection and ontology-driven clinical practice guideline criteria risk assessment is a simple and effective method for automating hereditary cancer risk screening.

Indexed as

clinical practice guidelinesconsumer health informaticshereditary cancerrestful APIrisk assessmentservice-oriented architecture

Identifiers

PMID35099392
PMCPMC8845001
OpenAlexW4205104784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.